Last $0.14 USD
Change Today -0.06 / -30.00%
Volume 12.4K
PANG On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

panacea global inc (PANG) Snapshot

Open
$0.30
Previous Close
$0.20
Day High
$0.30
Day Low
$0.14
52 Week High
04/28/14 - $1.00
52 Week Low
12/1/14 - $0.0030
Market Cap
14.9M
Average Volume 10 Days
14.7K
EPS TTM
$-0.03
Shares Outstanding
106.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PANACEA GLOBAL INC (PANG)

Related News

No related news articles were found.

panacea global inc (PANG) Related Businessweek News

No Related Businessweek News Found

panacea global inc (PANG) Details

Panacea Global, Inc., a development stage biopharmaceutical company, focuses on the provision of blood, serum, and tissue tests to diagnose and monitor cancer. The company, through a license agreement with Panacea Pharmaceuticals, Inc., sells early detection cancer tests. It focuses on the development of novel proteins and biochemical pathways related to cellular regulation and cell cycle abnormalities in oncology diseases. The company’s blood and serum tests include BC Detect, an in vitro serum test to detect and identify recurrence of breast cancer; CC Detect, an in vitro serum test to detect and identify recurrence of colorectal cancer; LC Detect, an in vitro serum test to detect and identify recurrence of lung cancer; PC Detect, an in vitro serum test to detect and identify recurrence of prostate cancer; and TK Sense, a RT-PCR test that predicts the response of patients with chronic myelogenous leukemia to the drug imatinib. Panacea Global, Inc. is based in Richmond Hill, Canada.

3 Employees
Last Reported Date: 03/31/14

panacea global inc (PANG) Top Compensated Officers

Chief Executive Officer, President, Chief Fin...
Total Annual Compensation: --
Vice President, Secretary and Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

panacea global inc (PANG) Key Developments

Panacea Global, Inc. Announces Auditor Changes

On September 5, 2014, the Board of Directors of Panacea Global, Inc. dismissed EFP Rotenberg, LLP as its independent registered public accounting firm. On September 5, 2014, the Board of Directors of the company engaged GBH CPAs, PC as its independent registered public accounting firm.

Panacea Global, Inc. Presents at 2nd Global Life Sciences Conference, Oct-02-2014 03:00 PM

Panacea Global, Inc. Presents at 2nd Global Life Sciences Conference, Oct-02-2014 03:00 PM. Venue: Warsaw Stock Exchange, Trading Floor, Ksiazeca 4, Warsaw, Poland. Speakers: Haleh Samimi, Marketing Director, Ladan Shariat, Member of Advisory Board, Mahmood Moshiri, Chief Executive Officer, President, Chief Financial Officer, Chief Medical Officer, Principal Accounting Officer and Director.

Panacea Global Deleted From OTCBB

Panacea Global, Inc.’s common stock has been deleted from OTC Bulletin Board (OTCBB) effective July 17, 2014 on account of its ineligibility for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PANG:US $0.14 USD -0.06

PANG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PANG.
View Industry Companies
 

Industry Analysis

PANG

Industry Average

Valuation PANG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PANACEA GLOBAL INC, please visit www.panaceaglobalinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.